Digital Pathology Systems

Digital Pathology Systems

Global Digital Pathology Systems Market to Reach $1.4 Billion by 2027
In the changed post COVID-19 business landscape, the global market for Digital Pathology Systems estimated at US$573.9 Million in the year 2020, is projected to reach a revised size of US$1.4 Billion by 2027, growing at a CAGR of 13.9% over the analysis period 2020-2027. Device, one of the segments analyzed in the report, is projected to record a 13.8% CAGR and reach US$753.1 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Software segment is readjusted to a revised 14.6% CAGR for the next 7-year period.

The U.S. Market is Estimated at $241.7 Million, While China is Forecast to Grow at 15.1% CAGR
The Digital Pathology Systems market in the U.S. is estimated at US$241.7 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$114.2 Million by the year 2027 trailing a CAGR of 15.1% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 10.9% and 12.6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 12.8% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$68.5 Million by the year 2027.

Other Segments Segment to Record 12.7% CAGR
In the global Other Segments segment, USA, Canada, Japan, China and Europe will drive the 12.7% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$86.6 Million in the year 2020 will reach a projected size of US$200.3 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Latin America will expand at a 12.5% CAGR through the analysis period.

Select Competitors (Total 74 Featured) -

  • 3DHISTECH Ltd.
  • Apollo Enterprise Imaging Corp.
  • Carl Zeiss AG
  • Corista LLC
  • Glencoe Software, Inc
  • Hamamatsu Photonics K.K.
  • Huron Digital Pathology, Inc.
  • Indica Labs
  • Inspirata Inc
  • KANTERON SYSTEMS S.L.U
  • KONFOONG BIOTECH INTERNATIONAL CO.,LTD
  • Leica Biosystems Nussloch GmbH
  • MikroScan Technologies
  • Inc.
  • Objective Pathology Services
  • Olympus Corporation
  • OptraSCAN, Inc
  • Philips Healthcare
  • Proscia Inc
  • Sectra AB
  • Visiopharm A/S
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
COVID-19 Ushers in 2020 as the Year of Healthcare Digitalization
Global Venture Capital Investments in Digital Health Startups (In US$ Billion)
% Share VC Investments by Category for 2020
FDA Temporarily Relaxes Guidelines to Promote Remote Digital Pathology Services amid COVID-19 Pandemic
COVID-19 Highlights Need to Implement Structured Online Curriculum for Pathology Training
Future Outlook of Pathology Post-COVID-19
Digital Pathology Systems – Global Key Competitors Percentage Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
Digital Pathology: An Introduction
Key Digital Pathology Tools
Market Outlook
US and Europe Maintain Dominance
Emerging Markets to Experience Strong Growth
Scanners Lead Digital Pathology Market
Software Segment Post Strong Growth
Disease Diagnosis: Major Application of Digital Pathology Systems
Telepathology Experiences Strong Growth
Pharmaceutical and Biotechnology Companies: Important End Use Markets for Digital Pathology
Global Digital Pathology Systems Market by End-Use: 2020
Major Issues Hampering Adoption of Digital Pathology Systems
Competitive Landscape
Market Share of Leading Players in Digital Pathology Systems Market: 2020E
Recent Market Activity
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Technological Advancements Drive Adoption of Digital Pathology Systems
Artificial Intelligence (AI) Steps in to Widen the Scope & Span of Digital Pathology
EXIBIT: AI Spending in Healthcare & Lifesciences in US$ Million for Years 2020 & 2025
Advantages of AI-Powered Digital Pathology
Digital Pathology Benefits Drug Discovery Process
Need for Early Diagnosis Puts Focus on Digital Pathology
Digital Pathology Systems See Fast Paced Adoption in Cancer and Other Chronic Diseases
Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
Number of New Cancer Cases and Deaths (in Million) by Region for 2018
Global New Cancer Cases and Cancer-related Deaths by Cancer Site (in %) for 2018
Digital Pathology Emerges as a Tool to Reduce Cases of Cancer Misdiagnoses
Scarcity of Pathologists & Excess Workload on Pathology Labs Drives Demand for Digital Systems
Clinical Research Continues to be Core Vertical for Digital Pathology
Digital Imaging and Robotic Light Microscopy Boost Growth
Computational Pathology for Leading-Edge Image Analytics
Cloud Platform Gains Momentum
Telepathology Expected to Pave Way for Pathology Outsourcing to Developing Nations
Rise in Significance of Personalized Medicine Bodes Well for Digital Pathology
Global Personalized Medicine Market: Revenues in US$ Million for the Years 2019 and 2024
Increased Focus on Companion Diagnostics to Benefit Market Growth
Improving Healthcare & Research Expenditure to Support Growth
World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023
Aging Population: A Key Opportunity Indicator
Global Aging Population: Population of 65+ Individuals (in Thousands) by Region for 2019 and 2030
Global Population of 65+ Individuals as % of Total Population by Region for 2019 and 2030
Global Cancer Deaths by Age Group (in %) for 2019
Challenges Facing Digital Pathology Systems Market
High Costs
Workflow Integration with Other Related Functions
Other Issues
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Recent Past, Current & Future Analysis for Digital Pathology Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 2: World Historic Review for Digital Pathology Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 3: World 12-Year Perspective for Digital Pathology Systems by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2021 & 2027
TABLE 4: World Recent Past, Current & Future Analysis for Device by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 5: World Historic Review for Device by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 6: World 12-Year Perspective for Device by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2021 & 2027
TABLE 7: World Recent Past, Current & Future Analysis for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 8: World Historic Review for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 9: World 12-Year Perspective for Software by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2021 & 2027
TABLE 10: World Recent Past, Current & Future Analysis for Other Segments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 11: World Historic Review for Other Segments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 12: World 12-Year Perspective for Other Segments by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2021 & 2027
TABLE 13: World Recent Past, Current & Future Analysis for Human Pathology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 14: World Historic Review for Human Pathology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 15: World 12-Year Perspective for Human Pathology by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2021 & 2027
TABLE 16: World Recent Past, Current & Future Analysis for Veterinary Pathology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 17: World Historic Review for Veterinary Pathology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 18: World 12-Year Perspective for Veterinary Pathology by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2021 & 2027
TABLE 19: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 20: World Historic Review for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 21: World 12-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2021 & 2027
TABLE 22: World Recent Past, Current & Future Analysis for Hospitals & Reference Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 23: World Historic Review for Hospitals & Reference Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 24: World 12-Year Perspective for Hospitals & Reference Labs by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2021 & 2027
TABLE 25: World Recent Past, Current & Future Analysis for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 26: World Historic Review for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 27: World 12-Year Perspective for Academic & Research Institutes by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2021 & 2027
III. MARKET ANALYSIS
UNITED STATES
Digital Pathology Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E)
COVID-19 Triggers Demand for Digital Pathology
Market Overview
Increasing Pressure on Pathological Labs: Cornerstone for Growth
TABLE 28: USA Recent Past, Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 29: USA Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 30: USA 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Revenues for Device, Software and Other Segments for the Years 2015, 2021 & 2027
TABLE 31: USA Recent Past, Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 32: USA Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 33: USA 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Revenues for Human Pathology and Veterinary Pathology for the Years 2015, 2021 & 2027
TABLE 34: USA Recent Past, Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 35: USA Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 36: USA 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Revenues for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2021 & 2027
CANADA
TABLE 37: Canada Recent Past, Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 38: Canada Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 39: Canada 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Revenues for Device, Software and Other Segments for the Years 2015, 2021 & 2027
TABLE 40: Canada Recent Past, Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 41: Canada Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 42: Canada 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Revenues for Human Pathology and Veterinary Pathology for the Years 2015, 2021 & 2027
TABLE 43: Canada Recent Past, Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 44: Canada Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 45: Canada 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Revenues for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2021 & 2027
JAPAN
Digital Pathology Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E)
Market Overview
TABLE 46: Japan Recent Past, Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 47: Japan Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 48: Japan 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Revenues for Device, Software and Other Segments for the Years 2015, 2021 & 2027
TABLE 49: Japan Recent Past, Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 50: Japan Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 51: Japan 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Revenues for Human Pathology and Veterinary Pathology for the Years 2015, 2021 & 2027
TABLE 52: Japan Recent Past, Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 53: Japan Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 54: Japan 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Revenues for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2021 & 2027
CHINA
Digital Pathology Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E)
Market Overview
TABLE 55: China Recent Past, Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 56: China Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 57: China 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Revenues for Device, Software and Other Segments for the Years 2015, 2021 & 2027
TABLE 58: China Recent Past, Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 59: China Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 60: China 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Revenues for Human Pathology and Veterinary Pathology for the Years 2015, 2021 & 2027
TABLE 61: China Recent Past, Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 62: China Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 63: China 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Revenues for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2021 & 2027
EUROPE
Digital Pathology Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E)
Market Overview
TABLE 64: Europe Recent Past, Current & Future Analysis for Digital Pathology Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 65: Europe Historic Review for Digital Pathology Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 66: Europe 12-Year Perspective for Digital Pathology Systems by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2021 & 2027
TABLE 67: Europe Recent Past, Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 68: Europe Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 69: Europe 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Revenues for Device, Software and Other Segments for the Years 2015, 2021 & 2027
TABLE 70: Europe Recent Past, Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 71: Europe Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 72: Europe 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Revenues for Human Pathology and Veterinary Pathology for the Years 2015, 2021 & 2027
TABLE 73: Europe Recent Past, Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 74: Europe Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 75: Europe 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Revenues for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2021 & 2027
FRANCE
Digital Pathology Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E)
TABLE 76: France Recent Past, Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 77: France Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 78: France 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Revenues for Device, Software and Other Segments for the Years 2015, 2021 & 2027
TABLE 79: France Recent Past, Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 80: France Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 81: France 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Revenues for Human Pathology and Veterinary Pathology for the Years 2015, 2021 & 2027
TABLE 82: France Recent Past, Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 83: France Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 84: France 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Revenues for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2021 & 2027
GERMANY
Digital Pathology Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E)
TABLE 85: Germany Recent Past, Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 86: Germany Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 87: Germany 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Revenues for Device, Software and Other Segments for the Years 2015, 2021 & 2027
TABLE 88: Germany Recent Past, Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 89: Germany Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 90: Germany 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Revenues for Human Pathology and Veterinary Pathology for the Years 2015, 2021 & 2027
TABLE 91: Germany Recent Past, Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 92: Germany Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 93: Germany 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Revenues for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2021 & 2027
ITALY
TABLE 94: Italy Recent Past, Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 95: Italy Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 96: Italy 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Revenues for Device, Software and Other Segments for the Years 2015, 2021 & 2027
TABLE 97: Italy Recent Past, Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 98: Italy Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 99: Italy 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Revenues for Human Pathology and Veterinary Pathology for the Years 2015, 2021 & 2027
TABLE 100: Italy Recent Past, Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 101: Italy Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 102: Italy 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Revenues for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2021 & 2027
UNITED KINGDOM
Digital Pathology Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E)
TABLE 103: UK Recent Past, Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 104: UK Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 105: UK 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Revenues for Device, Software and Other Segments for the Years 2015, 2021 & 2027
TABLE 106: UK Recent Past, Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 107: UK Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 108: UK 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Revenues for Human Pathology and Veterinary Pathology for the Years 2015, 2021 & 2027
TABLE 109: UK Recent Past, Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 110: UK Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 111: UK 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Revenues for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2021 & 2027
SPAIN
TABLE 112: Spain Recent Past, Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 113: Spain Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 114: Spain 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Revenues for Device, Software and Other Segments for the Years 2015, 2021 & 2027
TABLE 115: Spain Recent Past, Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 116: Spain Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 117: Spain 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Revenues for Human Pathology and Veterinary Pathology for the Years 2015, 2021 & 2027
TABLE 118: Spain Recent Past, Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 119: Spain Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 120: Spain 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Revenues for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2021 & 2027
RUSSIA
TABLE 121: Russia Recent Past, Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 122: Russia Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 123: Russia 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Revenues for Device, Software and Other Segments for the Years 2015, 2021 & 2027
TABLE 124: Russia Recent Past, Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 125: Russia Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 126: Russia 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Revenues for Human Pathology and Veterinary Pathology for the Years 2015, 2021 & 2027
TABLE 127: Russia Recent Past, Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 128: Russia Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 129: Russia 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Revenues for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2021 & 2027
REST OF EUROPE
TABLE 130: Rest of Europe Recent Past, Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 131: Rest of Europe Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 132: Rest of Europe 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Revenues for Device, Software and Other Segments for the Years 2015, 2021 & 2027
TABLE 133: Rest of Europe Recent Past, Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 134: Rest of Europe Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 135: Rest of Europe 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Revenues for Human Pathology and Veterinary Pathology for the Years 2015, 2021 & 2027
TABLE 136: Rest of Europe Recent Past, Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 137: Rest of Europe Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 138: Rest of Europe 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Revenues for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2021 & 2027
ASIA-PACIFIC
Digital Pathology Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E)
Market Overview
TABLE 139: Asia-Pacific Recent Past, Current & Future Analysis for Digital Pathology Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 140: Asia-Pacific Historic Review for Digital Pathology Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 141: Asia-Pacific 12-Year Perspective for Digital Pathology Systems by Geographic Region - Percentage Breakdown of Value Revenues for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2021 & 2027
TABLE 142: Asia-Pacific Recent Past, Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 143: Asia-Pacific Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 144: Asia-Pacific 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Revenues for Device, Software and Other Segments for the Years 2015, 2021 & 2027
TABLE 145: Asia-Pacific Recent Past, Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 146: Asia-Pacific Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 147: Asia-Pacific 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Revenues for Human Pathology and Veterinary Pathology for the Years 2015, 2021 & 2027
TABLE 148: Asia-Pacific Recent Past, Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 149: Asia-Pacific Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 150: Asia-Pacific 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Revenues for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2021 & 2027
AUSTRALIA
Digital Pathology Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2022 (E)
TABLE 151: Australia Recent Past, Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 152: Australia Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 153: Australia 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Revenues for Device, Software and Other Segments for the Years 2015, 2021 & 2027
TABLE 154: Australia Recent Past, Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 155: Australia Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 156: Australia 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Revenues for Human Pathology and Veterinary Pathology for the Years 2015, 2021 & 2027
TABLE 157: Australia Recent Past, Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 158: Australia Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 159: Australia 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Revenues for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2021 & 2027
INDIA
Digital Pathology Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2022 (E)
Market Overview
Inadequate Infrastructure Impedes Adoption of Telepathology
TABLE 160: India Recent Past, Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 161: India Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 162: India 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Revenues for Device, Software and Other Segments for the Years 2015, 2021 & 2027
TABLE 163: India Recent Past, Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 164: India Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 165: India 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Revenues for Human Pathology and Veterinary Pathology for the Years 2015, 2021 & 2027
TABLE 166: India Recent Past, Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 167: India Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 168: India 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Revenues for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2021 & 2027
SOUTH KOREA
TABLE 169: South Korea Recent Past, Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 170: South Korea Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 171: South Korea 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Revenues for Device, Software and Other Segments for the Years 2015, 2021 & 2027
TABLE 172: South Korea Recent Past, Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 173: South Korea Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 174: South Korea 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Revenues for Human Pathology and Veterinary Pathology for the Years 2015, 2021 & 2027
TABLE 175: South Korea Recent Past, Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 176: South Korea Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 177: South Korea 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Revenues for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2021 & 2027
REST OF ASIA-PACIFIC
TABLE 178: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 179: Rest of Asia-Pacific Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 180: Rest of Asia-Pacific 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Revenues for Device, Software and Other Segments for the Years 2015, 2021 & 2027
TABLE 181: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 182: Rest of Asia-Pacific Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 183: Rest of Asia-Pacific 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Revenues for Human Pathology and Veterinary Pathology for the Years 2015, 2021 & 2027
TABLE 184: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 185: Rest of Asia-Pacific Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 186: Rest of Asia-Pacific 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Revenues for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2021 & 2027
LATIN AMERICA
Digital Pathology Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2022 (E)
TABLE 187: Latin America Recent Past, Current & Future Analysis for Digital Pathology Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 188: Latin America Historic Review for Digital Pathology Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 189: Latin America 12-Year Perspective for Digital Pathology Systems by Geographic Region - Percentage Breakdown of Value Revenues for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2021 & 2027
TABLE 190: Latin America Recent Past, Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 191: Latin America Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 192: Latin America 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Revenues for Device, Software and Other Segments for the Years 2015, 2021 & 2027
TABLE 193: Latin America Recent Past, Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 194: Latin America Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 195: Latin America 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Revenues for Human Pathology and Veterinary Pathology for the Years 2015, 2021 & 2027
TABLE 196: Latin America Recent Past, Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 197: Latin America Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 198: Latin America 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Revenues for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2021 & 2027
ARGENTINA
TABLE 199: Argentina Recent Past, Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 200: Argentina Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 201: Argentina 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Revenues for Device, Software and Other Segments for the Years 2015, 2021 & 2027
TABLE 202: Argentina Recent Past, Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 203: Argentina Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 204: Argentina 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Revenues for Human Pathology and Veterinary Pathology for the Years 2015, 2021 & 2027
TABLE 205: Argentina Recent Past, Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 206: Argentina Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 207: Argentina 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Revenues for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2021 & 2027
BRAZIL
TABLE 208: Brazil Recent Past, Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 209: Brazil Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 210: Brazil 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Revenues for Device, Software and Other Segments for the Years 2015, 2021 & 2027
TABLE 211: Brazil Recent Past, Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 212: Brazil Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 213: Brazil 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Revenues for Human Pathology and Veterinary Pathology for the Years 2015, 2021 & 2027
TABLE 214: Brazil Recent Past, Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 215: Brazil Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 216: Brazil 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Revenues for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2021 & 2027
MEXICO
TABLE 217: Mexico Recent Past, Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 218: Mexico Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 219: Mexico 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Revenues for Device, Software and Other Segments for the Years 2015, 2021 & 2027
TABLE 220: Mexico Recent Past, Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 221: Mexico Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 222: Mexico 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Revenues for Human Pathology and Veterinary Pathology for the Years 2015, 2021 & 2027
TABLE 223: Mexico Recent Past, Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 224: Mexico Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 225: Mexico 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Revenues for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2021 & 2027
REST OF LATIN AMERICA
TABLE 226: Rest of Latin America Recent Past, Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 227: Rest of Latin America Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 228: Rest of Latin America 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Revenues for Device, Software and Other Segments for the Years 2015, 2021 & 2027
TABLE 229: Rest of Latin America Recent Past, Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 230: Rest of Latin America Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 231: Rest of Latin America 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Revenues for Human Pathology and Veterinary Pathology for the Years 2015, 2021 & 2027
TABLE 232: Rest of Latin America Recent Past, Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 233: Rest of Latin America Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 234: Rest of Latin America 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Revenues for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2021 & 2027
MIDDLE EAST
Digital Pathology Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2022 (E)
TABLE 235: Middle East Recent Past, Current & Future Analysis for Digital Pathology Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 236: Middle East Historic Review for Digital Pathology Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 237: Middle East 12-Year Perspective for Digital Pathology Systems by Geographic Region - Percentage Breakdown of Value Revenues for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2021 & 2027
TABLE 238: Middle East Recent Past, Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 239: Middle East Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 240: Middle East 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Revenues for Device, Software and Other Segments for the Years 2015, 2021 & 2027
TABLE 241: Middle East Recent Past, Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 242: Middle East Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 243: Middle East 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Revenues for Human Pathology and Veterinary Pathology for the Years 2015, 2021 & 2027
TABLE 244: Middle East Recent Past, Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 245: Middle East Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 246: Middle East 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Revenues for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2021 & 2027
IRAN
TABLE 247: Iran Recent Past, Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 248: Iran Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 249: Iran 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Revenues for Device, Software and Other Segments for the Years 2015, 2021 & 2027
TABLE 250: Iran Recent Past, Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 251: Iran Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 252: Iran 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Revenues for Human Pathology and Veterinary Pathology for the Years 2015, 2021 & 2027
TABLE 253: Iran Recent Past, Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 254: Iran Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 255: Iran 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Revenues for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2021 & 2027
ISRAEL
TABLE 256: Israel Recent Past, Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 257: Israel Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 258: Israel 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Revenues for Device, Software and Other Segments for the Years 2015, 2021 & 2027
TABLE 259: Israel Recent Past, Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 260: Israel Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 261: Israel 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Revenues for Human Pathology and Veterinary Pathology for the Years 2015, 2021 & 2027
TABLE 262: Israel Recent Past, Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 263: Israel Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 264: Israel 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Revenues for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2021 & 2027
SAUDI ARABIA
TABLE 265: Saudi Arabia Recent Past, Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 266: Saudi Arabia Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 267: Saudi Arabia 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Revenues for Device, Software and Other Segments for the Years 2015, 2021 & 2027
TABLE 268: Saudi Arabia Recent Past, Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 269: Saudi Arabia Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 270: Saudi Arabia 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Revenues for Human Pathology and Veterinary Pathology for the Years 2015, 2021 & 2027
TABLE 271: Saudi Arabia Recent Past, Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 272: Saudi Arabia Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 273: Saudi Arabia 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Revenues for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2021 & 2027
UNITED ARAB EMIRATES
TABLE 274: UAE Recent Past, Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 275: UAE Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 276: UAE 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Revenues for Device, Software and Other Segments for the Years 2015, 2021 & 2027
TABLE 277: UAE Recent Past, Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 278: UAE Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 279: UAE 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Revenues for Human Pathology and Veterinary Pathology for the Years 2015, 2021 & 2027
TABLE 280: UAE Recent Past, Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 281: UAE Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 282: UAE 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Revenues for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2021 & 2027
REST OF MIDDLE EAST
TABLE 283: Rest of Middle East Recent Past, Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 284: Rest of Middle East Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 285: Rest of Middle East 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Revenues for Device, Software and Other Segments for the Years 2015, 2021 & 2027
TABLE 286: Rest of Middle East Recent Past, Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 287: Rest of Middle East Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 288: Rest of Middle East 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Revenues for Human Pathology and Veterinary Pathology for the Years 2015, 2021 & 2027
TABLE 289: Rest of Middle East Recent Past, Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 290: Rest of Middle East Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 291: Rest of Middle East 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Revenues for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2021 & 2027
AFRICA
Digital Pathology Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2022 (E)
TABLE 292: Africa Recent Past, Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 293: Africa Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 294: Africa 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Revenues for Device, Software and Other Segments for the Years 2015, 2021 & 2027
TABLE 295: Africa Recent Past, Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 296: Africa Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 297: Africa 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Revenues for Human Pathology and Veterinary Pathology for the Years 2015, 2021 & 2027
TABLE 298: Africa Recent Past, Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 299: Africa Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
TABLE 300: Africa 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Revenues for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2021 & 2027
IV. COMPETITION
Total Companies Profiled: 74

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings